Indeed, other mechanisms for the reduced expression or function of E-cadherin, such as transcriptional downregulation, promoter methylation of CDH1, and post-translational modifications of E-cadherin, have been detected in breast cancer [61,64,65,66,67,68]. This evidence concerns the gene CDH1 and breast carcinoma.